直觉外科公司尽管第四季度初步营收超预期，但股价仍遭遇抛售，这并不完全令人意外。Baird分析师David Rescott在报告中指出："2026财年手术量增长指引略低于市场买方已消化的预期。"他补充称，全球设备使用率增长环比持平，并提及"在医疗科技板块表现疲软的背景下，本周多数预披露企业存在下行倾向"。不过Rescott认为，该公司2026年指引可能偏向保守，这或为后续业绩超预期留下空间。直觉外科股价当前下跌3.8%。
（本文完）道琼斯通讯社
2026年1月14日12:44 ET（17:44 GMT）
版权所有（c）2026 道琼斯公司
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.